Cryolife Q2 EPS $0.12 Beats $(0.05) Estimate, Sales $76.15M Beat $70.97M Estimate
Author: Benzinga Newsdesk | July 29, 2021 04:44pm
Cryolife (NYSE:
CRY) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $(0.05) by 340 percent. This is a 700 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $76.15 million which beat the analyst consensus estimate of $70.97 million by 7.30 percent. This is a 41.62 percent increase over sales of $53.77 million the same period last year.
Posted In: CRY